Synfacts 2019; 15(06): 0671
DOI: 10.1055/s-0037-1612570
Chemistry in Medicine and Biology
© Georg Thieme Verlag Stuttgart · New York

LYTACs for the Degradation of Secreted and Membrane Proteins

Dirk Trauner
Nynke A. Vepřek
Banik SM, Pedram K, Wisnovsky S, Riley NM, Bertozzi CR. * Stanford University and Howard Hughes Medical Institute, Stanford, USA
Lysosome Targeting Chimeras (LYTACs) for the Degradation of Secreted and Membrane Proteins.

ChemRxiv 2019;
DOI: 10.26434/chemrxiv.7927061.v1.
Further Information

Publication History

Publication Date:
20 May 2019 (online)



Lysosomal degradation makes use of cell-surface lysosomal targeting receptors (LTR), which facilitate the transport of proteins into the lysosome. The authors developed so-called LYTACs, which are chimeric molecules that can bind both an extracellular protein and an LTR, allowing for degradation of non-cytosolic proteins of interest in the lysosome. LYTACs are complementary to PROTACs (proteolysis targeting chimeras), which primarily target cytosolic proteins.



Mannose-6-phosphate receptor M6PR (or IGF2R) recognizes and binds mannose-6-phosphate residues on proteins and transports them to the lysosome for degradation. The LYTACs presented herein use glycopolypeptides of varying length, which can be attached to an antibody for the POI in a modular fashion using click chemistry. The versatile applicability is demonstrated by successfully targeting different extracellular proteins.